Previously, we showed that HER3 binds to anexelekto (AXL), maintains cell survival, and induces cell tolerance to the EGFR-TKI osimertinib via the ERK-SPRY4 axis in EGFR mutant-NSCLC cells17. This evidence concerns the gene SPRY4 and non-small cell lung carcinoma.